CVS Health Corporation (CVS) News

CVS Health Corporation (CVS): $85.98

0.73 (+0.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter CVS News Items

CVS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CVS News Highlights

  • CVS's 30 day story count now stands at 44.
  • Over the past 27 days, the trend for CVS's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
  • OSH, DRUG and WBA are the most mentioned tickers in articles about CVS.

Latest CVS News From Around the Web

Below are the latest news stories about CVS HEALTH CORP that investors may wish to consider to help them evaluate CVS as an investment opportunity.

Upcoming CVS Earnings – Is It Time to Buy?

Coming up on February 8th, 2023, ahead of the opening bell, CVS Health Corporation (CVS) is set to release financial results for the fourth quarter of 2022.

Yahoo | February 6, 2023

7 Overvalued Stocks That Will Get Clobbered This Year

Despite stocks' generally positive outlook, there are still many overvalued stocks to sell at this point.

Larry Ramer on InvestorPlace | February 5, 2023

CVS Should Have No Problem Delivering 10% EPS Growth (NYSE:CVS)

CVS Health EPS guidance implies about 10% EPS growth rates, which we think is achievable. Read more to see why I rate CVS stock a buy.

Seeking Alpha | February 5, 2023

Pinterest, Chipotle, Lyft, CVS: Earnings to watch next week

Yahoo Finance Live’s Rachelle Akuffo discusses the earnings expectations for companies like Pinterest, Chipotle, and Lyft.

Yahoo | February 3, 2023

Fee request estimate submitted to city for six-story hotel project at CVS site in Midtown Sacramento

In another sign of hospitality's resurgence, a new hotel is being considered at a site in Midtown Sacramento. City planners received a request for estimated fees on a six-story, 155-room hotel at 1701 K St. this week. The site is currently occupied by a CVS Pharmacy.

Yahoo | February 3, 2023

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $86.18 in the latest trading session, marking a -1.5% move from the prior day.

Yahoo | February 2, 2023

Attorney Generals Of Several States Warn CVS, Walgreens Against Mailing Abortion Medication

Republican attorneys general in 20 states warned CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc (NASDAQ: WBA) against mailing abortion pills in their jurisdictions. Also Read: Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow. “We emphasize that it is our responsibility as State Attorneys General to uphold the law and protect the health, safety, and well-being of women and unborn children in our states,” the attorney generals said in lett

Yahoo | February 2, 2023

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Yahoo | February 2, 2023

Mailing abortion pills could break law, Republican AGs tell pharmacies

A group of 20 Republican state attorneys general on Wednesday told Walgreens Boots Alliance Inc and CVS Health Corp that they risk running afoul of federal and state law if they dispense the abortion drug mifepristone by mail. The move, announced by Missouri Attorney General Andrew Bailey, comes weeks after the U.S. Food and Drug Administration for the first time allowed retail pharmacies to dispense mifepristone, including by mail, provided they are certified under special safety rules for the drug. Walgreens and CVS have said they intend to become certified and dispense the drug in states where abortion is legal, though neither has yet done so.

Yahoo | February 2, 2023

CVS Health (CVS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 1, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5511 seconds.